Dopamine receptor ligands

Details Dopamine receptor ligands Dopamine receptor ligands

1996-05-03

1998-08-25

Grumbling, Matthew V.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514218, 514254, 514321, 514324, 544377, 544378, 546197, 546202, 540575, 540596, A61K 31495, A61K 31435, C07D40114, C07D40314

Patent

active

057983500

ABSTRACT:
Described herein are D4 receptor-selective compounds of the general formula: ##STR1## wherein: A and B are independently selected, optionally substituted, saturated or unsaturated 5- or 6-membered, homo- or heterocyclic rings;

REFERENCES:
patent: 3539573 (1970-11-01), Schmutz et al.
patent: 3546226 (1970-12-01), Schmutz et al.
patent: 3751415 (1973-08-01), Schmutz et al.
patent: 3758479 (1973-09-01), Schmutz et al.
patent: 3884922 (1975-05-01), Nakanishi et al.
patent: 3908010 (1975-09-01), Schmutz et al.
patent: 3983234 (1976-09-01), Sayers
patent: 4096261 (1978-06-01), Horrum et al.
patent: 5354747 (1994-10-01), Hansen, Jr. et al.
Coyne et al., "Antiinflammatory Dialkylaminoalkylureas", J. Med. Chem., vol. 10:541-546, (1967).
Fitton et al., "Clozapine: A Review Of Its Pharmacological Properties, And Therapeutic Use in Schizophrenia", Drugs, vol. 40:722-747, (1990).
Krogh et al., "Compendium of Pharmaceuticals and Specialties", Canadian Pharmaceutical Association, 28th ed., (1993).
Lahti et al., "Dopamine D.sub.4 Versus D.sub.2 Receptor Selectivity of Dopamine Receptor Antagonists: Possible Therapeutic Implications", European Journal of Pharmacology, vol. 236:483-486, (1993).
Seeman et al., "Dopamine D.sub.2 Receptor Binding Sites For Agonists", Molecular Pharmacology, vol. 28:391-399, (1985).
Seeman et al., "Dopamine D.sub.4 Receptors Bind Inactive (+)-aporphines, Suggesting Neuroleptic Role. Sulpiride Not Stereoselective", European Journal of Pharmacology, vol. 233:173-174, (1993).
Seeman et al., "Dopamine D4 Receptors Elevated in Schizopphrenia", Nature, vol. 365:441-445, (1993).
Van Tol et al., "Cloning of The Gene For A Human Dopamine D.sub.4 Receptor With High Affinity For the Antipsychotic Clozapine", Nature, vol. 350:610-614, (1991).
Van Tol et al., "Multiple Dopamine D.sub.4 Receptor Variants In The Human Population", Nature, vol. 358:149-152, (1992).
Protiva et al., "Chemical Abstracts", vol. 90, No. 121655, (1978).
Jilek et al., "Chemical Abstracts", vol. 85, No. 46576, (1975).
Giani et al., "A New Facile Synthesis of 11-Oxo-10, Synthesis, 1985, pp. 550-552. Clozapine and Spiroperidol Binding Sites in Rat Brain.sup.1 ", J. Med. Chem., 1982, 35, pp. 855-858.
Klunder et al., "Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2. Tricyclic Pyridobenzoxazepinones and Dibenzoxazepinones", J. Med. Chem., 1992, 35, pp. 1887-1897.
de Paulis et al., "Synthesis of Clozapine Analogues and Their Affinity for Clozapine and Spiroperidol Binding Sites in Rat Brain.sup.1 ", J. Med. Chem., vol. 24, No. 9, Sep. 1981, pp. 1021-1026.
Sindelar et al., "Noncataleptic Potential Neuroleptics: 2-Nitro and 2-Hydroxy Derivatives of 10-(4-Methyl piperazino)-10, Commun., 42, 1977, pp. 2231-2239.

Affiliated with

Also associated with

Rating

Dopamine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopamine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine receptor ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-36443